论文部分内容阅读
单疱性角膜炎是一种世界性的常见病,目前虽已有不少抗病毒药物问世,可惜仍未能根治本病。很多病者由于长期反复发作,视力逐渐下降、终则致盲。为了控制炎症或挽救视力,50年代已有报告用角膜移植治疗此病。经过三十多年经验的积累,加上角膜移植技术上的进展,现在治疗此病,效果良好,已成为一种公认的治疗方法。但什么情况下适于角膜移植,似乎还未有很细致明确的统一认识,其原因相信和本病在临床过程中的复杂性有很大关系。 50年代初用角膜移植治疗此病吋,也曾把浅层单疱性角膜炎也作为手术对象。可以理解,当时对单疱性角膜炎的认识没有今天
Unilateral bullous keratitis is a worldwide common disease, although there are many anti-viral drugs available, but unfortunately still not cure the disease. Many patients due to long-term recurrent, gradually decreased visual acuity, and ultimately blinding. In the 1950s there have been reports of corneal transplantation for the treatment of inflammation or saving vision. After thirty years of accumulated experience, coupled with advances in corneal transplantation technology, the treatment of the disease now, the effect is good, has become a recognized treatment. However, under what circumstances suitable for corneal transplantation, it seems that there is no very clear and unified understanding of the reasons for this disease believe that the complexity of the clinical course have a great relationship. The early 50s to treat the disease with corneal transplantation, also had superficial bullous keratitis as a surgical object. Understandably, at that time, the understanding of the unicellular keratitis did not exist today